Anti-alpha Synuclein (phospho S129) antibody [EP1536Y]

• Supplier: Abcam
• Catalog: ab51253
• Prices: $397.00
• Sizes: 100 µl
• Host: Rabbit
• Clonality: Monoclonal
• Isotype: IgG
• Clone: EP1536Y
• Applications: WB ICC/IF ICC/IF
• Species Reactivities: Mouse, Rat, Human
• Antigen: A phosphor-specific peptide corresponding to residues surrounding Serine 129 of human alpha Synuclein
• Blocking Peptide: alpha Synuclein (phospho S129) peptide
• Description: Rabbit Monoclonal
• Gene: SNCA
• Conjugate: Unconjugated

Product images

All lanes : Anti-alpha Synuclein (phospho S129) antibody [EP1536Y] (ab51253) at 1/5000 dilutionLane 1 : Fetal brain lysate, untreatedLane 2 : Fetal brain lysate, treated with APLysates/proteins at 10 µg per lane.SecondaryGoat anti-Rabbit HRP labeled at 1/2000 dilution

Product References

A30P alpha-Synuclein interferes with the stable integration of adult-born neurons - A30P alpha-Synuclein interferes with the stable integration of adult-born neurons

Neuner J, Filser S, Michalakis S, Biel M, Herms J. Sci Rep. 2014 Feb 3;4:3931.

Zonisamide attenuates alpha-synuclein neurotoxicity by an aggregation-independent - Zonisamide attenuates alpha-synuclein neurotoxicity by an aggregation-independent

Arawaka S, Fukushima S, Sato H, Sasaki A, Koga K, Koyama S, Kato T. PLoS One. 2014 Feb 20;9(2):e89076.

Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent - Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent

Perez-Revuelta BI, Hettich MM, Ciociaro A, Rotermund C, Kahle PJ, Krauss S, Di Monte DA. Cell Death Dis. 2014 May 8;5:e1209.

Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. - Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.

Spinelli KJ, Taylor JK, Osterberg VR, Churchill MJ, Pollock E, Moore C, Meshul CK, Unni VK. J Neurosci. 2014 Feb 5;34(6):2037-50.

Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem - Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem

Kellie JF, Higgs RE, Ryder JW, Major A, Beach TG, Adler CH, Merchant K, Knierman MD. Sci Rep. 2014 Jul 23;4:5797.

Is there a risk of prion-like disease transmission by Alzheimer- or - Is there a risk of prion-like disease transmission by Alzheimer- or

Beekes M, Thomzig A, Schulz-Schaeffer WJ, Burger R. Acta Neuropathol. 2014 Oct;128(4):463-76.

Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast - Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast

Wang S, Zhang S, Liou LC, Ren Q, Zhang Z, Caldwell GA, Caldwell KA, Witt SN. Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):E3976-85. doi:

Time course and progression of wild type alpha-synuclein accumulation in a - Time course and progression of wild type alpha-synuclein accumulation in a

Amschl D, Neddens J, Havas D, Flunkert S, Rabl R, Romer H, Rockenstein E, Masliah E, Windisch M, Hutter-Paier B. BMC Neurosci. 2013 Jan 9;14:6.

rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia - rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia

Oliveras-Salva M, Van der Perren A, Casadei N, Stroobants S, Nuber S, D'Hooge R, Van den Haute C, Baekelandt V. Mol Neurodegener. 2013 Nov 25;8:44.

Alterations in axonal transport motor proteins in sporadic and experimental - Alterations in axonal transport motor proteins in sporadic and experimental

Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH. Brain. 2012 Jul;135(Pt 7):2058-73.